Detalhe da pesquisa
1.
Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regions.
Genome Res
; 34(4): 539-555, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38719469
2.
Double-strand break toxicity is chromatin context independent.
Nucleic Acids Res
; 50(17): 9930-9947, 2022 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36107780
3.
Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets.
Breast Cancer Res
; 22(1): 85, 2020 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32782013
4.
Breast cancer risk SNPs converge on estrogen receptor binding sites commonly shared between breast tumors to locally alter estrogen signalling output.
bioRxiv
; 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37961147
5.
Perturbations in 3D genome organization can promote acquired drug resistance.
Cell Rep
; 42(10): 113124, 2023 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37733591
6.
Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential.
Nat Commun
; 13(1): 7367, 2022 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36450752
7.
MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling.
Nat Commun
; 13(1): 6579, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36323660
8.
IHC-based Ki67 as response biomarker to tamoxifen in breast cancer window trials enrolling premenopausal women.
NPJ Breast Cancer
; 7(1): 138, 2021 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34671036
9.
Age-correlated protein and transcript expression in breast cancer and normal breast tissues is dominated by host endocrine effects.
Nat Cancer
; 1(5): 518-532, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35121983
10.
The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor-Positive Breast Cancers.
Mol Cancer Res
; 18(7): 1018-1027, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32245803
11.
IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis.
Cancer Cell
; 38(3): 412-423.e9, 2020 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32679107
12.
Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer.
Nat Commun
; 9(1): 482, 2018 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29396493